Vicente Valero Selected Research

Aftercare (After-Treatment)

1/2018	Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.
1/2018	Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
12/2015	Prognosis for patients with metastatic breast cancer who achieve a no-evidence-of-disease status after systemic or local therapy.
11/2002	Global gene expression changes during neoadjuvant chemotherapy for human breast cancer.
7/2002	Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vicente Valero Research Topics

Disease

199	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
125	Neoplasms (Cancer) 03/2024 - 04/2002
43	Pathologic Complete Response 11/2023 - 06/2002
30	Triple Negative Breast Neoplasms 04/2024 - 09/2008
20	Inflammatory Breast Neoplasms 04/2024 - 08/2005
20	Neoplasm Metastasis (Metastasis) 11/2018 - 07/2002
11	Disease Progression 04/2024 - 04/2002
11	Residual Neoplasm 01/2023 - 01/2007
7	Cardiotoxicity 02/2022 - 11/2002
7	Fatigue 12/2021 - 02/2004
6	Circulating Neoplastic Cells 03/2023 - 07/2009
6	Carcinoma (Carcinomatosis) 10/2013 - 06/2005
5	Neutropenia 01/2021 - 02/2013
5	Fistula 01/2019 - 02/2016
4	Heart Failure 09/2019 - 11/2002
4	Pancreatic Fistula (Pancreatic Fistulas) 01/2019 - 02/2016
4	Lymphatic Metastasis 04/2016 - 03/2006
4	Pathologic Constriction (Stenosis) 06/2013 - 06/2002
4	Lacrimal Apparatus Diseases (Epiphora) 06/2013 - 06/2002
3	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2019 - 11/2005
3	Febrile Neutropenia 01/2018 - 01/2011
3	Infections 02/2016 - 01/2006
3	Thrombocytopenia (Thrombopenia) 01/2011 - 07/2002
2	Left Ventricular Dysfunction 02/2022 - 11/2005
2	Brain Neoplasms (Brain Tumor) 03/2021 - 09/2006
2	Sepsis (Septicemia) 01/2021 - 04/2015
2	Fever (Fevers) 01/2021 - 07/2003
2	Necrosis 01/2021 - 01/2017
2	Frailty 03/2020 - 02/2015
2	Body Weight (Weight, Body) 03/2020 - 04/2007
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 02/2013
2	Margins of Excision 04/2018 - 02/2003
2	Stroke (Strokes) 01/2018 - 06/2015
2	Adenocarcinoma 12/2016 - 09/2014

Drug/Important Bio-Agent (IBA)

33	Trastuzumab (Herceptin)FDA Link 11/2023 - 04/2002
32	Estrogen ReceptorsIBA 11/2023 - 05/2002
30	AnthracyclinesIBA 06/2023 - 04/2002
27	Hormones (Hormone)IBA 01/2022 - 09/2004
24	Docetaxel (Taxotere)FDA Link 01/2019 - 01/2002
22	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 06/2002
21	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 06/2002
19	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 05/2002
18	Biomarkers (Surrogate Marker)IBA 04/2024 - 03/2005
18	taxaneIBA 01/2021 - 03/2003
16	human ERBB2 proteinIBA 01/2023 - 12/2009
14	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 05/2002
13	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2007
12	Progesterone Receptors (Progesterone Receptor)IBA 10/2020 - 02/2003
10	Capecitabine (Xeloda)FDA Link 07/2019 - 08/2003
10	Tamoxifen FDA LinkGeneric 01/2016 - 05/2002
9	Estrogens (Estrogen)FDA Link 01/2019 - 02/2003
8	pertuzumabIBA 11/2023 - 10/2016
8	Ado-Trastuzumab EmtansineIBA 11/2022 - 10/2016
8	Taxoids (Taxanes)IBA 01/2020 - 05/2002
8	Carboplatin (JM8)FDA LinkGeneric 01/2019 - 01/2011
7	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2004
6	Epidermal Growth Factor (EGF)IBA 10/2020 - 06/2011
6	Bevacizumab (Avastin)FDA Link 04/2017 - 07/2010
5	Phenobarbital (Luminal)FDA Link 03/2024 - 05/2009
5	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2008
5	ixabepilone (BMS 247550)FDA Link 10/2015 - 01/2011
5	Messenger RNA (mRNA)IBA 01/2013 - 01/2007
4	Aromatase InhibitorsIBA 10/2023 - 03/2004
4	Epirubicin (Ellence)FDA LinkGeneric 01/2021 - 01/2007
4	Lapatinib (GW572016)FDA Link 07/2019 - 07/2010
4	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 01/2008
4	Gemcitabine FDA Link 01/2018 - 09/2003
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2017 - 01/2002
4	Anastrozole (Arimidex)FDA LinkGeneric 02/2012 - 06/2002
3	N-acetyltalosaminuronic acid (NAT)IBA 03/2024 - 09/2015
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2023 - 07/2009
3	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2015
3	liposomal doxorubicin (Doxil)FDA Link 04/2017 - 04/2002
3	Selective Estrogen Receptor Modulators (SERM)IBA 01/2016 - 03/2004
2	Dasatinib (BMS 354825)FDA Link 10/2023 - 10/2014
2	130-nm albumin-bound paclitaxelIBA 06/2023 - 01/2018
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023 - 04/2017
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 08/2006
2	CytokinesIBA 08/2019 - 02/2004
2	Letrozole (Femara)FDA LinkGeneric 07/2019 - 12/2018
2	exemestane (Aromasin)FDA Link 01/2019 - 03/2004
2	tipifarnib (R115777)IBA 01/2018 - 10/2013
2	Keratins (Keratin)IBA 12/2016 - 11/2005
2	Indicators and Reagents (Reagents)IBA 08/2016 - 01/2016

Therapy/Procedure

86	Therapeutics 04/2024 - 04/2002
71	Drug Therapy (Chemotherapy) 04/2024 - 04/2002
69	Neoadjuvant Therapy 03/2024 - 07/2002
23	Radiotherapy 10/2023 - 07/2002
12	Mastectomy (Mammectomy) 08/2021 - 07/2002
8	Adjuvant Chemotherapy 01/2019 - 05/2002
7	Segmental Mastectomy (Lumpectomy) 04/2018 - 10/2002
5	Aftercare (After-Treatment) 01/2018 - 07/2002
5	Mammaplasty (Breast Reconstruction) 03/2017 - 12/2008
4	Combination Drug Therapy (Combination Chemotherapy) 12/2014 - 04/2010
3	Pancreatectomy 01/2019 - 02/2015
3	Pancreaticoduodenectomy 01/2018 - 02/2016
3	Transplantation 06/2015 - 01/2015
2	Chemoprevention 10/2023 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 09/2020 - 07/2008
2	Simple Mastectomy 02/2016 - 12/2008